Corcept Therapeutics Incorporated (CORT)

Fixed asset turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	US$ in thousands	675,040	482,375	401,858	365,978	353,874
Property, plant and equipment	US$ in thousands	—	—	1,776	1,002	1,675
Fixed asset turnover		—	—	226.27	365.25	211.27

December 31, 2024 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $675,040K ÷ $—K
= —

Fixed asset turnover measures how efficiently a company generates revenue from its investments in fixed assets. In the case of Corcept Therapeutics Incorporated, the fixed asset turnover has shown significant fluctuations over the past few years.

As of December 31, 2020, the fixed asset turnover ratio was 211.27, indicating that for every dollar invested in fixed assets, the company generated $211.27 in revenue. This high ratio suggests efficient utilization of fixed assets in generating sales.

By December 31, 2021, the fixed asset turnover ratio increased to 365.25, reflecting a substantial improvement in efficiency in generating revenue from fixed assets. Corcept Therapeutics appeared to have made effective use of its fixed assets to boost sales.

However, by December 31, 2022, the fixed asset turnover ratio dropped to 226.27. This decrease signals a decline in the company's ability to generate revenue from its fixed assets efficiently compared to the previous year.

Unfortunately, there is no data available for December 31, 2023, and December 31, 2024, making it difficult to assess the trend in fixed asset turnover for those periods.

In conclusion, the fluctuating trend in Corcept Therapeutics' fixed asset turnover indicates varying levels of efficiency in utilizing fixed assets to generate revenue. It is important for the company to monitor and improve this ratio to ensure optimal asset utilization and revenue generation in the future.